The DOI matches its Crossref record.
Internationalization of Traditional/Complementary Medicine products: market entry as medicine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to the ‘light touch’ regulatory frameworks in many countries, including the USA and Australia, access to DS products does not require consultation or interaction with a healthcare professional, and these products can be easily accessed through pharmacy, retail and online outlets [25, 26].”
From The Use of Medications and Dietary Supplements by Masters Athletes—A Review (2022) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 19
- Zhong F. The current development status and prospect on Chinese medicine health foods. China Health Ind. 2014;11(10):187–8.
- Nirali J, Shankar M. Global market analysis of herbal drug formulations. Int J Ayu Pharm Chem. 2016;4(1):59–65.
- Lin AX, Chan G, Hu Y, Ouyang D, Ung CO, Shi L, Hu H. Internationalization of traditional Chinese medicine: Current international market, internationalization challenges and prospective suggestions. Chin Med. 2018;13(1):9. https://doi.org/10.1186/s13020-018-0167-z . · DOI
- Wu G. International opportunities and challenges of Chinese medicine. Co-op Econ Sci. 2015;11:83–4.
- Wu WY, Hou JJ, Long HL, Yang WZ, Liang J, Guo DA. TCM-based new drug discovery and development in China. Chin J Nat Med. 2014;12(4):0241–50.
- Jiang M, Yang J, Zhang C, Liu B, Chan K, Cao H, Lu A. Clinical studies with traditional Chinese medicine in the past decade and future research and development. Planta Med. 2010;76(17):2048–64. · DOI
- Zhang H, Wang N, Zheng L. The influence of acceding to WTO on progress of modernization of Chinese materia medica in the 21st century. China Pharm. 2000;11(2):51–3.
- Zhang L. Discuss on the export barriers and countermeasures of traditional Chinese medicine. Chin Bus Trade. 2011;7:204–5.
- Alostad A, Steinke D, Schafheutle E. International comparison of five herbal medicine registration systems to inform regulation development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain. Pharmaceut Med. 2018;32(1):39–49.
- Graham D. Regulation of proprietary traditional Chinese medicines in Australia. Chin J Nat Med. 2017;15(1):12–4.
- Kroes B. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union. Eur J Integr Med. 2014;6(6):701. · DOI
- van Galen E. Traditional herbal medicines worldwide, from reappraisal to assessment in Europe. J Ethnopharmacol. 2014;158:498–502. · DOI
- Cranz H, Anquez-Traxler C. TradReg 2013: regulation of herbal and traditional medicinal products—European and global strategies—international symposium. J Ethnopharmacol. 2014;158:495–7. · DOI
- Wiesener S, Falkenberg T, Hegyi G, Hök J, di Sarsina PR, Fønnebø V. Legal status and regulation of complementary and alternative medicine in Europe. Forsch Komplementmed. 2012;19(Suppl. 2):29–36. · DOI
- Fan TP, Deal G, Koo HL, et al. Future development of global regulations of Chinese herbal products. J Ethnopharmacol. 2012;140:568–86. · DOI · Paper page
- Wiesner J, Knöss W. Future visions for traditional and herbal medicinal products—a global practice for evaluation and regulation? J Ethnopharmacol. 2014;158:516–8. · DOI
- Shen J, Wang K, Hu Q, Su J, Zhang W. Establishment quality control method of traditional Chinese medicine based on efficacy and safety. Modernization Trad Chin Med Materia Med. 2014;3:502–5.
- Fleischer T, Su Y, Lin S. How do government regulations influence the ability to practice Chinese herbal medicine in western countries. J Ethnopharmacol. 2017;196:104–9. · DOI
- Ajazuddin SS. Legal regulations of complementary and alternative medicines in different countries. Pharmacogn Rev. 2012;6(12):154. · DOI
Cited by
Chen, Y.-G., He, X.-L.-S., Huang, J.-H., Luo, R., Ge, H.-Z., Wołowicz, A., Wawrzkiewicz, M., Gładysz-Płaska, A., Li, B., Yu, Q.-X., et al. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112336 · Cited by 192
The Use of Medications and Dietary Supplements by Masters Athletes—A Review
Harnett, J., Climstein, M., Walsh, J., & Gifford, J. (2022) · Current Nutrition Reports · doi:10.1007/s13668-022-00398-0 · Cited by 12
Self-citation
Metadata
- Authors
- Li, J., Zhu, J., Hu, H., Harnett, J. E., Lei, C. I., Chau, K. Y., Chan, G., & Ung, C. O. L.
- Venue
- Chinese Medicine
- Published
- 2018-10-11
- Volume
- 13
- Issue
- 1
- ISSN
- 1749-8546
- Cited by
- 34
- References
- 0
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
